Yuki Okumura

This inventor holds 13 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 9 EPO patents. Top assignees: Nihon Medi-Physics Company, Limited, National Hospital Organization, Ge Healthcare Limited. Active years: 2012-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuki Okumura. Retrieved from https://idiyas.com/inventor/yuki-okumura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 2)

% Patents Active = 69.2

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 9 (Patent Applications = 13)

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 6(Granted Patents)

Location History:

Chiba, JP (2013)
Sodegaura, JP (2012 - 2015)
Tokyo, JP (2019 - 2022)

Company Filing History:

12 out of 142

Nihon Medi-Physics Company, Limited

patents

3 out of 13

National Hospital Organization

patents

2 out of 191

Ge Healthcare Limited

where one patent can have more than one assignee

Years Active: 2012-2022

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11318216 - Method for producing radiohalogen-labeled compound and method for producing radiopharmaceutical (2022-05-03),

2. 11266753 - 2-[5-(imidazol-1-ylmethyl)pyridin-3-yl]benzimtdazole derivative compound, and medicament including same (2022-03-08),

3. 10894779 - Process for producing flutametamol (2021-01-19),

4. 10472338 - Method for producing [F]flutemetamol (2019-11-12),

5. 10358434 - 2-(3-pyridinyl)-1H-benzimidazole derivative compound and medicament containing same (2019-07-23),

6. 10189815 - 2-(3-pyridinyl)-1H-benzimidazole derivative compound and medicine containing same (2019-01-29),

7. 9211350 - Compound with amyloid affinity (2015-12-15),

8. 9149546 - Compound having affinity for amyloid (2015-10-06),

9. 9107964 - Radioactive fluorine-labeled compound (2015-08-18),

10. 8506930 - Compounds having affinity for amyloid (2013-08-13),

11. 8399672 - Compound having affinity for amyloid (2013-03-19),

12. 8303935 - Alkoxy substituted imidazo[1,2-a]pyridines having affinity for amyloid (2012-11-06),

13. 8207189 - Compound having affinity for amyloid (2012-06-26),

Title: Yuki Okumura: Innovator in Radiopharmaceuticals

Introduction

Yuki Okumura is a prominent inventor based in Tokyo, Japan, known for her significant contributions to the field of radiopharmaceuticals. With a total of 13 patents to her name, she has made remarkable advancements in the production of radiohalogen-labeled compounds and related technologies.

Latest Patents

Among her latest patents is a method for producing a radiohalogen-labeled compound. This method involves a series of steps, including the use of a radiohalogen-labeling precursor compound that undergoes a radiohalogenation reaction. The process results in a reaction mixture that contains both the precursor compound and the resulting radiohalogenated product. Additionally, she has developed a compound known as a 2-[5-(imidazol-1-ylmethyl)pyridin-3-yl]benzimidazole derivative, which has potential applications in medicinal chemistry.

Career Highlights

Yuki has worked with notable organizations such as Nihon Medi-Physics Company, Limited and the National Hospital Organization. Her work in these institutions has allowed her to focus on innovative solutions in the medical field, particularly in the development of radiopharmaceuticals.

Collaborations

Yuki has collaborated with esteemed colleagues, including Daisaku Nakamura and Shigeyuki Tanifuji. These partnerships have fostered a collaborative environment that enhances the research and development of new medical technologies.

Conclusion

Yuki Okumura's contributions to the field of radiopharmaceuticals exemplify her dedication to innovation and research. Her patents and collaborations continue to influence advancements in medical science, showcasing her role as a leading inventor in her field.

Profile summary based on public USPTO records.